Largest companies by net assets
net assets
| Company | Net assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 101 | $1.36B | Healthcare | Biotechnology | United States | Nasdaq |
| 102 | $1.35B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 103 | $1.35B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 104 | $1.35B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 105 | $1.34B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 106 | $1.33B | Healthcare | Medical Devices | United States | Nasdaq |
| 107 | $1.31B | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 108 | $1.31B | Healthcare | Healthcare Providers | United States | NYSE |
| 109 | $1.26B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 110 | $1.24B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 111 | $1.23B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 112 | $1.19B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 113 | $1.18B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 114 | $1.17B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 115 | $1.15B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 116 | $1.12B | Healthcare | Healthcare Providers | United States | NYSE |
| 117 | $1.12B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 118 | $1.11B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 119 | $1.11B | Healthcare | Healthcare Providers | United States | NYSE |
| 120 | $1.10B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 121 | $1.10B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 122 | $1.05B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 123 | $1.04B | Healthcare | Medical Devices | United States | Nasdaq |
| 124 | $1.04B | Healthcare | Medical Devices | United States | NYSE |
| 125 | $1.03B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 126 | $1.03B | Healthcare | Biotechnology | United States | Nasdaq |
| 127 | $1.03B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 128 | $1.02B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 129 | $1.01B | Healthcare | Pharmaceuticals | United States | NYSE |
| 130 | $1.00B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 131 | $999.24M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 132 | $967.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 133 | $943.52M | Healthcare | Health Services | United States | NYSE |
| 134 | $927.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 135 | $915.00M | Healthcare | Biotechnology | United States | Nasdaq |
| 136 | $903.12M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 137 | $897.00M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 138 | $896.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 139 | $895.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 140 | $890.01M | Healthcare | Biotechnology | United States | Nasdaq |
| 141 | $878.58M | Healthcare | Healthcare Providers | United States | NYSE |
| 142 | $841.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 143 | $837.10M | Healthcare | Medical Devices | United States | NYSE |
| 144 | $825.58M | Healthcare | Medical Devices | United States | NYSE |
| 145 | $825.55M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 146 | $813.61M | Healthcare | Pharmaceuticals | United States | NYSE |
| 147 | $782.33M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 148 | $757.49M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 149 | $736.04M | Healthcare | Biotechnology | United States | Nasdaq |
| 150 | $735.39M | Healthcare | Biotechnology | United States | Nasdaq |
| 151 | $705.78M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 152 | $702.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 153 | $682.88M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 154 | $682.49M | Healthcare | Medical Devices | United States | NYSE |
| 155 | $671.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 156 | $665.65M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 157 | $662.10M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 158 | $654.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 159 | $644.16M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 160 | $631.42M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 161 | $629.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 162 | $615.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 163 | $615.06M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 164 | $604.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 165 | $597.21M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 166 | $591.73M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 167 | $550.92M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 168 | $536.81M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 169 | $532.39M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 170 | $525.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 171 | $524.20M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 172 | $523.72M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 173 | $520.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 174 | $518.84M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 175 | $518.05M | Healthcare | Medical Devices | United States | Nasdaq |
| 176 | $516.43M | Healthcare | Medical Devices | United States | Nasdaq |
| 177 | $505.62M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 178 | $503.23M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 179 | $487.28M | Healthcare | Biotechnology | United States | Nasdaq |
| 180 | $484.84M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 181 | $477.10M | Healthcare | Healthcare Providers | United States | NYSE |
| 182 | $474.21M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 183 | $470.03M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 184 | $468.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 185 | $466.50M | Healthcare | Biotechnology | United States | Nasdaq |
| 186 | $466.19M | Healthcare | Health Services | United States | NYSE |
| 187 | $465.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 188 | $460.83M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 189 | $454.27M | Healthcare | Biotechnology | United States | Nasdaq |
| 190 | $453.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 191 | $453.26M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 192 | $453.12M | Healthcare | Biotechnology | United States | Nasdaq |
| 193 | $452.16M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 194 | $448.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 195 | $448.66M | Healthcare | Healthcare Providers | United States | NYSE |
| 196 | $448.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 197 | $445.74M | Healthcare | Biotechnology | United States | Nasdaq |
| 198 | $445.58M | Healthcare | Medical Devices | United States | NYSE |
| 199 | $439.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 200 | $436.18M | Healthcare | Biotechnology | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 724 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.